Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
about
DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD miceOmega 3 fatty acid for the prevention of cognitive decline and dementiaReduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2Cognitive impairment and stroke in elderly patientsDocosahexaenoic Acid and Cognition throughout the LifespanDHA Effects in Brain Development and FunctionEffect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled TrialsOmega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional InterventionsComponents of a Mediterranean diet and their impact on cognitive functions in agingVascular aspects of cognitive impairment and dementiaImportance and management of micronutrient deficiencies in patients with Alzheimer's diseaseEffects of vitamin E on cognitive performance during ageing and in Alzheimer's diseaseω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussionThe influence of the human microbiome and probiotics on cardiovascular healthDietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationEffects of Omega-3 Fatty Acid Supplementation on Cognitive Functions and Neural Substrates: A Voxel-Based Morphometry Study in Aged Mice.N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyEffects of N-3 Polyunsaturated Fatty Acids on DementiaOmega-3 fatty acids for breast cancer prevention and survivorshipGut Microbiota: A Modulator of Brain Plasticity and Cognitive Function in AgeingProtective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's DiseaseDocosahexaenoic acid (DHA): an ancient nutrient for the modern human brainAssociation of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.The role of nutrition on cognition and brain health in ageing: a targeted approach.Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid poolsRandomized controlled trial examining the effects of fish oil and multivitamin supplementation on the incorporation of n-3 and n-6 fatty acids into red blood cells.Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Endothelial Vasodilator Function and Cognition-Are They Interrelated?Adherence to a Mediterranean diet and plasma fatty acids: data from the Bordeaux sample of the Three-City study.A randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction.Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension.Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.Fish intake is associated with slower cognitive decline in Chinese older adults.Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderlyOmega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial?Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers.Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.
P2860
Q21135531-1C6D71BE-85AF-4B05-ABA6-C8936FAA885BQ24202649-F08BD398-8F27-402C-B426-3CB2BB38B396Q24314295-F9C415AA-AF07-45DE-B623-C0DCBD13F526Q26749183-1A46E61A-8110-41BF-88E6-5745197D5E9EQ26768442-EF66F544-C64D-480A-A4F8-25A38D1B4F15Q26770284-811DC86A-39A1-4E00-8AE8-DB409F14B1CEQ26770351-949C3047-AA33-4709-BA68-E2BE7801A6D3Q26782982-7C8B8DEF-C586-4DDF-858C-67B8AB73D2BAQ26798129-EF7A90C1-AA09-4943-9B75-FC8ABAE169D6Q26798765-A846F83C-3E4D-4483-BD64-16A295D81701Q26820823-1EC7DA10-A823-4E02-B50C-122261926998Q26852673-4B6F3F2B-5FA8-4804-8ED6-7071E3266F0FQ26864433-FBCBB07A-726A-404B-874E-E148192C5A1CQ26991937-40D8D261-0C97-47D3-ACCD-4E0AC8F5C23CQ26992191-5EDA4C33-17C7-4F7A-A7E4-8C9D291383A3Q27307991-DFFD2B19-7244-4AF8-BC1B-B55191C7A245Q27323288-25F07800-1EEA-497A-A33F-E60C2CCE70E2Q28072641-AB8FA7A0-2BA1-4F7F-B180-598E784BA153Q28075307-C17218FB-980E-49D7-A017-76083C9E24A6Q28080498-73814CCD-BBD8-4561-84D2-B06B5A219EC8Q28081092-A4323B78-72E3-4E2B-B564-6C941CAFACCAQ28551173-CEB11B61-8397-4CA4-AE61-7E7AABD4AB56Q28732836-A0D6CF0D-DA02-4FCA-8E68-824010153A05Q30238885-0C8D1E08-84F4-4499-B585-B8AD9ADCB0ADQ30779251-505FFD1F-F0C0-4BE8-ABE4-BF8121B1EC92Q31031167-EEDE41F9-A7BC-4EF7-9459-C8FE4EE70D80Q33668976-29EB08BE-22F9-486D-A994-64E0F5329172Q33701569-50AB20E0-8213-44A3-B3D8-22673183906DQ33749456-3636707D-6187-4E38-A2EE-76BEB9AD3604Q33814998-4BF731E7-69CC-4570-A67D-DC1EE454E918Q33858896-235E4618-7526-44D1-94E2-C1A528C4A5CEQ33944809-4CA09E91-57D4-4678-8CD2-6929AA6F1A84Q33963305-F054AFA1-943B-45E3-A840-67EBBC0A69F7Q34027672-A650F8A6-F630-4935-96EF-CE0281BC6F9AQ34171931-49B325A6-E1AB-4791-AF4A-F020889211F3Q34263507-33345900-68F1-49A1-9223-8DE42824003DQ34265517-C547C5B6-DAFA-4D3D-BFA5-FE74B76E74CCQ34290929-9B51D366-19D6-449A-BDD2-1BA4C700CAD0Q34322681-3A437FB0-3452-47B6-9610-ED1FB2A391FBQ34330929-2444BA38-5DD2-4D6C-A17E-43450AEFE8A5
P2860
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@ast
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@en
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@nl
type
label
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@ast
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@en
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@nl
prefLabel
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@ast
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@en
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@nl
P2093
P1476
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.
@en
P2093
Alan S Ryan
Andrew Blackwell
Deanna McCarthy
Edward B Nelson
Karin Yurko-Mauro
MIDAS Investigators
Mary Stedman
Norman Salem
P304
P356
10.1016/J.JALZ.2010.01.013
P577
2010-11-01T00:00:00Z